ArticleCancer research2024

Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells.

Li Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.